北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 期刊论文
学科主题: 临床医学
题名:
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PLERIXAFOR plus G-CSF VS PLACEBO plus G-CSF TO MOBILIZE a.5 X 106 CD34+CELLS/KG IN CHINESE NHL PATIENTS FOR AUTOLOGOUS TRANSPLANTATION
作者: Zhu, J.1; Huang, H.2; Chen, H.3; Zhang, X.4; Li, Z.5,6; Wu, D.7; Zhou, D.8; Song, Y.9; Hu, Y.10; Liang, Y.11; Ren, H.12; Huang, H.13; Li, N.14; Chen, H.15; Hu, J.16; Li, J.17; Meng, R.18; Ge, J.18; Wu, J.19; Huang, X.3
刊名: HAEMATOLOGICA
发表日期: 2015-06-01
卷: suppl.1, 页:284-284
收录类别: SCI ; ISTP
文章类型: Meeting Abstract
WOS标题词: Science & Technology
类目[WOS]: Hematology
研究领域[WOS]: Hematology
语种: 英语
WOS记录号: WOS:000361204902223
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/67235
Appears in Collections:北京大学第二临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Soochaw Univ, Affiliated Hosp 1, Suzhou, Peoples R China
2.Peking Univ, Hosp 1, Beijing 100871, Peoples R China
3.307 Hosp PLA, Beijing, Peoples R China
4.Shanghai Ruijin Hosp, Shanghai, Peoples R China
5.Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China
6.Sanofi R&D, Shanghai, Peoples R China
7.Sanofi R&D, Beijing, Peoples R China
8.Beijing Canc Hosp, Beijing, Peoples R China
9.Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
10.Third Mil Med Univ, Xinqiao Hosp, Chongqing, Peoples R China
11.CAMS, Inst Hematol, Tianjin, Peoples R China
12.CAMS, Hosp Blood Dis, Tianjin, Peoples R China
13.Beijing Union Med Coll Hosp, Beijing, Peoples R China
14.Huazhong Univ Sci Technol, Tongji Med Coll, Union Hosp, Wuhan, Hubei, Peoples R China
15.Mil Med Univ, Tangdu Hosp, Xian, Shanxi, Peoples R China
16.Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
17.Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Peoples R China
18.Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
19.Henan Prov Canc Hosp, Zhengzhou, Henan, Peoples R China

Recommended Citation:
Zhu, J.,Huang, H.,Chen, H.,et al. A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PLERIXAFOR plus G-CSF VS PLACEBO plus G-CSF TO MOBILIZE a.5 X 106 CD34+CELLS/KG IN CHINESE NHL PATIENTS FOR AUTOLOGOUS TRANSPLANTATION[J]. HAEMATOLOGICA,2015,suppl.1:284-284.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zhu, J.]'s Articles
[Huang, H.]'s Articles
[Chen, H.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zhu, J.]‘s Articles
[Huang, H.]‘s Articles
[Chen, H.]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace